Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.

Wojtala J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Dodel R, Schulz JB, Reetz K.

J Neurol Neurosurg Psychiatry. 2018 Oct 8. pii: jnnp-2018-319008. doi: 10.1136/jnnp-2018-319008. [Epub ahead of print]

PMID:
30297519
2.

[Dementia with Lewy bodies].

Dodel R, Koschel J, Lorenzl S, Levin J, van Eimeren T, Höglinger G.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S43-S47. doi: 10.1055/a-0696-6249. Epub 2018 Sep 21. German.

PMID:
30241100
3.

Quality of life in a German cohort of Parkinson's patients assessed with three different measures.

Balzer-Geldsetzer M, Klotsche J; LANDSCAPE Consortium, Dodel R, Riedel O.

J Neurol. 2018 Sep 12. doi: 10.1007/s00415-018-9047-9. [Epub ahead of print]

PMID:
30209651
4.

Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia.

Belger M, Haro JM, Reed C, Happich M, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.

Eur J Health Econ. 2018 Sep 3. doi: 10.1007/s10198-018-1001-3. [Epub ahead of print]

PMID:
30178148
5.

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.

Albus A, Gold M, Bach JP, Burg-Roderfeld M, Jördens M, Kirchhein Y, Kronimus Y, Mengel D, Zerr I, Dodel R.

PLoS One. 2018 Aug 29;13(8):e0202954. doi: 10.1371/journal.pone.0202954. eCollection 2018.

6.

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD).

Stankevich Y, Lueken U, Balzer-Geldsetzer M, Dodel R, Gräber-Sultan S, Berg D, Liepelt-Scarfone I, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Am J Geriatr Psychiatry. 2018 Oct;26(10):1079-1090. doi: 10.1016/j.jagp.2018.06.012. Epub 2018 Jun 30.

PMID:
30082208
7.

Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.

Mengel D, Fraune L, Sommer N, Stettner M, Reese JP, Dams J, Glynn RJ, Balzer-Geldsetzer M, Dodel R, Tackenberg B.

Muscle Nerve. 2018 Aug 2. doi: 10.1002/mus.26315. [Epub ahead of print]

PMID:
30073683
8.

[Inclusion Body Myopathy, Paget's Disease, and Fronto-temporal Dementia: a VCP-related Multi-systemic Proteinopathy].

Mengel D, Librizzi D, Schoser B, Gläser D, Clemen CS, Dodel R, Schröder R.

Fortschr Neurol Psychiatr. 2018 Jul;86(7):434-438. doi: 10.1055/s-0044-101033. Epub 2018 Jul 20. German.

PMID:
30029282
9.

IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.

Gu H, Kirchhein Y, Zhu T, Zhao G, Peng H, Du E, Liu J, Mastrianni JA, Farlow MR, Dodel R, Du Y.

Mol Neurobiol. 2018 Jul 19. doi: 10.1007/s12035-018-1228-0. [Epub ahead of print]

PMID:
30027340
10.

Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's Disease.

Hessmann P, Dodel R, Baum E, Müller MJ, Paschke G, Kis B, Zeidler J, Klora M, Reese JP, Balzer-Geldsetzer M.

Pharmacopsychiatry. 2018 Jan 31. doi: 10.1055/s-0044-100523. [Epub ahead of print]

PMID:
29388173
11.

Antidepressant medication in a German cohort of patients with Alzheimer's disease
.

Hessmann P, Dodel R, Baum E, Müller MJ, Paschke G, Kis B, Zeidler J, Klora M, Reese JP, Balzer-Geldsetzer M.

Int J Clin Pharmacol Ther. 2018 Mar;56(3):101-112. doi: 10.5414/CP203121.

PMID:
29350177
12.

Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood.

Kuhn I, Rogosch T, Schindler TI, Tackenberg B, Zemlin M, Maier RF, Dodel R, Kronimus Y.

J Neuroimmunol. 2018 Feb 15;315:33-39. doi: 10.1016/j.jneuroim.2017.12.003. Epub 2017 Dec 11.

PMID:
29306403
13.

Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany.

Hessmann P, Dodel R, Baum E, Müller MJ, Paschke G, Kis B, Zeidler J, Klora M, Reese JP, Balzer-Geldsetzer M.

Int J Psychiatry Clin Pract. 2018 Sep;22(3):232-239. doi: 10.1080/13651501.2017.1414269. Epub 2017 Dec 13.

PMID:
29235398
14.

Is treatment of geriatric hip fracture patients cost-covering? Results of a prospective study conducted at a German University Hospital.

Aigner R, Hack J, Eschbach D, Ruchholtz S, Knobe M, Dodel R, Buecking B.

Arch Orthop Trauma Surg. 2018 Mar;138(3):331-337. doi: 10.1007/s00402-017-2844-2. Epub 2017 Dec 2.

PMID:
29198046
15.

Comment: β-Amyloid pathology and Parkinson disease.

Dodel R.

Neurology. 2017 Dec 5;89(23):2339. doi: 10.1212/WNL.0000000000004756. Epub 2017 Nov 8. No abstract available.

PMID:
29117960
16.

Use of antidementia drugs in German patients with Alzheimer's disease.

Hessmann P, Dodel R, Baum E, Müller MJ, Paschke G, Kis B, Zeidler J, Klora M, Reese JP, Balzer-Geldsetzer M.

Int Clin Psychopharmacol. 2018 Mar;33(2):103-110. doi: 10.1097/YIC.0000000000000205.

PMID:
29112517
17.

Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.

Handels RLH, Wimo A, Dodel R, Kramberger MG, Visser PJ, Molinuevo JL, Verhey FRJ, Winblad B.

J Alzheimers Dis. 2017;60(4):1477-1487. doi: 10.3233/JAD-170324.

PMID:
29081416
18.

Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Strik H, Keber U, Hammoud WA, Riera-Knorrenschild J, Carl B, Dodel R, Pagenstecher A, Neubauer A.

Eur J Cancer. 2017 Dec;87:205-208. doi: 10.1016/j.ejca.2017.09.026. Epub 2017 Oct 16. No abstract available.

PMID:
29050806
19.

Predictors of noninstitutionalized survival 1 year after hip fracture: A prospective observational study to develop the Marburg Rehabilitation Tool for Hip fractures (MaRTHi).

Buecking B, Eschbach D, Knobe M, Oberkircher L, Balzer-Geldsetzer M, Dodel R, Sielski R, Doering B, Ruchholtz S, Bliemel C.

Medicine (Baltimore). 2017 Sep;96(37):e7820. doi: 10.1097/MD.0000000000007820.

20.

Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples.

Enders D, Balzer-Geldsetzer M, Riedel O, Dodel R, Wittchen HU, Sensken SC, Wolff B, Reese JP.

Eur Neurol. 2017;78(3-4):128-136. doi: 10.1159/000477165. Epub 2017 Jul 27.

PMID:
28746937
21.

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.

de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ.

J Parkinsons Dis. 2017;7(3):533-543. doi: 10.3233/JPD-161055.

22.

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.

Jones RW, Lebrec J, Kahle-Wrobleski K, Dell'Agnello G, Bruno G, Vellas B, Argimon JM, Dodel R, Haro JM, Wimo A, Reed C.

Dement Geriatr Cogn Dis Extra. 2017 Mar 20;7(1):87-100. doi: 10.1159/000461577. eCollection 2017 Jan-Apr.

23.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Review.

24.

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.

25.

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Int J Methods Psychiatr Res. 2017 Dec;26(4). doi: 10.1002/mpr.1564. Epub 2017 Apr 18.

PMID:
28418163
26.

Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning.

Voigt-Radloff S, de Werd MM, Leonhart R, Boelen DH, Olde Rikkert MG, Fliessbach K, Klöppel S, Heimbach B, Fellgiebel A, Dodel R, Eschweiler GW, Hausner L, Kessels RP, Hüll M.

Alzheimers Res Ther. 2017 Mar 23;9(1):22. doi: 10.1186/s13195-017-0247-9.

27.

What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.

J Alzheimers Dis. 2017;57(3):797-812. doi: 10.3233/JAD-160449.

PMID:
28304285
28.

[Differences Between Self- and Proxy-Assessment of Health-Related Quality of Life in Patients with Mild Cognitive Impairment and Alzheimer's Disease].

Heßmann P, Dreier M, Brandes I, Dodel R, Baum E, Müller MJ, Balzer-Geldsetzer M.

Psychiatr Prax. 2018 Mar;45(2):78-86. doi: 10.1055/s-0042-121169. Epub 2017 Feb 27. German.

PMID:
28241372
29.

How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.

Health Qual Life Outcomes. 2017 Jan 21;15(1):16. doi: 10.1186/s12955-017-0591-2.

30.

Synthesis of a biological active β-hairpin peptide by addition of two structural motifs.

Fischer S, Lamping M, Gold M, Röttger Y, Brödje D, Dodel R, Frantz R, Mraheil MA, Chakraborty T, Geyer A.

Bioorg Med Chem. 2017 Jan 15;25(2):603-608. doi: 10.1016/j.bmc.2016.11.022. Epub 2016 Nov 15.

PMID:
27887962
31.

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.

Kronimus Y, Albus A, Balzer-Geldsetzer M, Straub S, Semler E, Otto M, Klotsche J, Dodel R; LANDSCAPE Consortium, Mengel D.

PLoS One. 2016 Nov 1;11(11):e0164953. doi: 10.1371/journal.pone.0164953. eCollection 2016.

32.

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.

Kortland LM, Alfter A, Bähr O, Carl B, Dodel R, Freiman TM, Hubert K, Jahnke K, Knake S, von Podewils F, Reese JP, Runge U, Senft C, Steinmetz H, Rosenow F, Strzelczyk A.

Epilepsia. 2016 Dec;57(12):2056-2066. doi: 10.1111/epi.13584. Epub 2016 Oct 18.

33.

Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications.

Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R; EARLYSTIM-investigators.

Mov Disord. 2016 Aug;31(8):1183-91. doi: 10.1002/mds.26740.

PMID:
27506638
34.

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, Moccia M, Mollenhauer B, Oertel W, Suenkel U, Walter U, Wirdefeldt K, Liepelt-Scarfone I, Maetzler W, Berg D.

Front Aging Neurosci. 2016 Jun 22;8:147. doi: 10.3389/fnagi.2016.00147. eCollection 2016. Review.

35.

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.

Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.

BMC Med Res Methodol. 2016 Jul 18;16:83. doi: 10.1186/s12874-016-0188-1.

36.

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8.

PMID:
27401782
37.

An economic evaluation of deep brain stimulation for patients with Parkinson's disease.

Dams J, Dodel R.

Mov Disord. 2016 Aug;31(8):1122-4. doi: 10.1002/mds.26701. Epub 2016 Jun 21. Review. No abstract available.

PMID:
27324696
38.

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.

Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R.

Parkinsonism Relat Disord. 2016 Aug;29:112-6. doi: 10.1016/j.parkreldis.2016.04.013. Epub 2016 Apr 19.

PMID:
27321987
39.

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D.

Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. No abstract available.

40.

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.

Fengler S, Roeske S, Heber I, Reetz K, Schulz JB, Riedel O, Wittchen HU, Storch A, Linse K, Baudrexel S, Hilker R, Mollenhauer B, Witt K, Schmidt N, Balzer-Geldsetzer M, Dams J, Dodel R, Gräber S, Pilotto A, Petrelli A, Fünkele S, Kassubek J, Kalbe E.

Psychol Med. 2016 Aug;46(11):2275-86. doi: 10.1017/S0033291716000908. Epub 2016 May 19.

PMID:
27193073
41.

Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.

Heßmann P, Seeberg G, Reese JP, Dams J, Baum E, Müller MJ, Dodel R, Balzer-Geldsetzer M.

J Alzheimers Dis. 2016;51(2):545-61. doi: 10.3233/JAD-150835.

PMID:
26890754
42.

Pre-fracture quality of life predicts 1-year survival in elderly patients with hip fracture-development of a new scoring system.

Bliemel C, Sielski R, Doering B, Dodel R, Balzer-Geldsetzer M, Ruchholtz S, Buecking B.

Osteoporos Int. 2016 Jun;27(6):1979-87. doi: 10.1007/s00198-015-3472-8. Epub 2016 Jan 5.

PMID:
26733375
43.

Reduction of glutamate-induced excitotoxicity in murine primary neurons involving calpain inhibition.

Gold M, Koczulla AR, Mengel D, Koepke J, Dodel R, Dontcheva G, Habib P, Bach JP.

J Neurol Sci. 2015 Dec 15;359(1-2):356-62. doi: 10.1016/j.jns.2015.11.016. Epub 2015 Nov 11.

PMID:
26671142
44.

TREM2 rare variant p.R47H is not associated with Parkinson's disease.

Mengel D, Thelen M, Balzer-Geldsetzer M, Söling C, Bach JP, Schaeffer E, Herold C, Becker T, Liepelt I, Becker J, Riedel-Heller S, Scherer M, Jessen F, Maier W, Dodel R, Ramirez A.

Parkinsonism Relat Disord. 2016 Feb;23:109-11. doi: 10.1016/j.parkreldis.2015.11.026. Epub 2015 Nov 25.

PMID:
26651418
45.

Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF model.

van Uem JM, Marinus J, Canning C, van Lummel R, Dodel R, Liepelt-Scarfone I, Berg D, Morris ME, Maetzler W.

Neurosci Biobehav Rev. 2016 Feb;61:26-34. doi: 10.1016/j.neubiorev.2015.11.014. Epub 2015 Dec 2. Review.

PMID:
26645499
46.

Activation of SK2 channels preserves ER Ca²⁺ homeostasis and protects against ER stress-induced cell death.

Richter M, Vidovic N, Honrath B, Mahavadi P, Dodel R, Dolga AM, Culmsee C.

Cell Death Differ. 2016 May;23(5):814-27. doi: 10.1038/cdd.2015.146. Epub 2015 Nov 20.

47.

How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer's Disease Patients?

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.

Value Health. 2015 Nov;18(7):A760. doi: 10.1016/j.jval.2015.09.2482. Epub 2015 Oct 20. No abstract available.

48.

Comparing Resource Use In Alzheimer's Disease Across Three European Countries - 18-Month Results of The Geras Study.

Belger M, Argimon JM, Dodel R, Haro JM, Wimo A, Reed C.

Value Health. 2015 Nov;18(7):A759-60. doi: 10.1016/j.jval.2015.09.2479. Epub 2015 Oct 20. No abstract available.

49.

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Sünkel U, Walter U, Wirdefeldt K, Berg D.

Neuroepidemiology. 2015;45(4):282-97. doi: 10.1159/000439221. Epub 2015 Nov 3.

50.

How pain empathy depends on ingroup/outgroup decisions: A functional magnet resonance imaging study.

Ruckmann J, Bodden M, Jansen A, Kircher T, Dodel R, Rief W.

Psychiatry Res. 2015 Oct 30;234(1):57-65. doi: 10.1016/j.pscychresns.2015.08.006. Epub 2015 Aug 20.

PMID:
26323252

Supplemental Content

Support Center